Real-World Burden of Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

Real-World Burden of Nonalcoholic Steatohepatitis

Published:2021-05 Issue:5 Volume:19 Page:1020-1029.e7
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Geier Andreas,Rinella Mary E.^ORCID,Balp Maria-Magdalena^ORCID,McKenna Sarah Jane,Brass Clifford A.,Przybysz Raymond^ORCID,Cai Jennifer,Knight Amanda,Gavaghan Meghan,Howe Tanya,Rosen Daniel,Ratziu Vlad

Funder

Novartis Pharma

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy;Kopec;Nutr Clin Pract,2011

2. The natural course of non-alcoholic fatty liver disease;Calzadilla Bertot;Int J Mol Sci,2016

3. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;LaBrecque;J Clin Gastroenterol,2014

4. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

5. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances;Noureddin;Am J Gastroenterol,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD;Life Sciences;2024-10

2. Budget impact of resmetirom for the treatment of adults with non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis);Journal of Medical Economics;2024-08-22

3. Estimating the economic impact of comorbidities in patients with MASH and defining high-cost burden in patients with noncirrhotic MASH;Hepatology Communications;2024-07-22

4. Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study;BMC Medicine;2024-06-03

5. Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies;Alimentary Pharmacology & Therapeutics;2024-05-30